https://www.selleckchem.com/pr....oducts/etanercept.ht
50% of CHD cases occurred in pregnancies not associate with any (fetal or maternal) risk factor. The sensitivity, and specificity for prenatal CHD detection were 91.7% and 100% respectively. Our study indicates that a substantial proportion of CHD cases occur in women not having high risk of giving birth to children with CHD. FE is a highly sensitive and specific test with strong predictive values. We recommend that FE should be done in every pregnancy. Our study indicates that a substantial proportion of CHD cases occur in women not
Like
Comment
Share
